Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 63
ID1129ThPPIDTh1018NameSecretinPeptide SequenceHSDGTFTSELSRLRDSARLQ Full viewLength27Functional ClassificationIVDiseaseHormonal disordersBrandSecreFloCompanyRepligen CorpPhysical AppearanceLyophilized white powderRoute of AdministartionIntravenous infusionCategoryDiagnostic Agents TargetSecretin receptor
ID1130ThPPIDTh1018NameSecretinPeptide SequenceHSDGTFTSELSRLRDSARLQ Full viewLength27Functional ClassificationIVDiseaseHormonal disordersBrandSecremaxCompanyRepligen CorpPhysical AppearanceSolutionRoute of AdministartionIntravenousCategoryDiagnostic Agents TargetSecretin receptor
ID1205ThPPIDTh1027NameInsulin RegularPeptide SequenceA-chain:GIVEQCCTSIC< Full viewLength51Functional ClassificationIaDiseaseGenetic/HormonalBrandHumulin RCompanyEli Lilly and CompanyPhysical AppearanceSterile, clear, aqueous, and colorless solutionRoute of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.CategoryAntidiabetic Agents TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206ThPPIDTh1027NameInsulin RegularPeptide SequenceA-chain:GIVEQCCTSIC< Full viewLength51Functional ClassificationIaDiseaseGenetic/HormonalBrandNovolin RCompanyNovo NordiskPhysical AppearanceSterile, clear, aqueous, and colorless solutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryAntidiabetic Agents TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1215ThPPIDTh1029NameMenotropinsPeptide SequenceAlpha-Chain(LH):APD< Full viewLength222Functional ClassificationIbDiseaseHormonal disordersBrandMenopurCompanyN.A.Physical AppearanceSterile, lyophilized powder which is reconstitution with sterile 0.9% Sodium Chloride Injection.Route of AdministartionSubcutaneous InjectionCategoryFertility Agents TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor
ID1216ThPPIDTh1029NameMenotropinsPeptide SequenceAlpha-Chain(LH):APD< Full viewLength222Functional ClassificationIbDiseaseHormonal disordersBrandRepronexCompanyN.A.Physical AppearanceSterile, lyophilized formRoute of AdministartionSubcutaneous or Intramuscular Injection.CategoryFertility Agents TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor
ID1252ThPPIDTh1035NameGlucagon recombinantPeptide SequenceHSQGTFTSDYSKYLDSRRAQ Full viewLength29Functional ClassificationIVDiseaseHormonal/Metabolic/geneticBrandGlucaGenCompanyNovo NordiskPhysical AppearanceSterile, lyophilized white powderRoute of AdministartionSubcutaneous, Intramuscular, or Intravenous infusionCategoryHypoglycemic Agents TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor
ID1253ThPPIDTh1035NameGlucagon recombinantPeptide SequenceHSQGTFTSDYSKYLDSRRAQ Full viewLength29Functional ClassificationIVDiseaseHormonal/Metabolic/geneticBrandGlucagonCompanyEli LillyPhysical AppearancePowderRoute of AdministartionSubcutaneously or Intramuscularly InjectionCategoryHypoglycemic Agents TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor
ID1269ThPPIDTh1039NameLutropin alfaPeptide SequenceAlpha Chain: APDVQDC Full viewLength213Functional ClassificationIbDiseaseHormonalBrandLuverisCompanySeronoPhysical AppearanceWhite lyophilised pellet withg clear colourless solvent to make solutionRoute of AdministartionSubcutaneous (SC) administrationCategoryFertility Agents TargetLutropin-choriogonadotropic hormone receptor
ID1275ThPPIDTh1040NameInsulin LisproPeptide SequenceA chain:GIVEQCCTSICS Full viewLength51Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandHumalogCompanyEli LillyPhysical AppearanceSterile, aqueous, clear, and colorless solutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1276ThPPIDTh1040NameInsulin LisproPeptide SequenceA chain:GIVEQCCTSICS Full viewLength51Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandHumalog KwikPenCompanyEli LillyPhysical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1277ThPPIDTh1040NameInsulin LisproPeptide SequenceA chain:GIVEQCCTSICS Full viewLength51Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandHumalog PenCompanyEli LillyPhysical AppearanceN.A.Route of AdministartionN.A.CategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1283ThPPIDTh1041NameInsulin GlarginePeptide SequenceA-chain:GIVEQCCTSICS Full viewLength53Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandLantusCompanySanofi-AventisPhysical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1284ThPPIDTh1041NameInsulin GlarginePeptide SequenceA-chain:GIVEQCCTSICS Full viewLength53Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandLantus OptiSetCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1285ThPPIDTh1041NameInsulin GlarginePeptide SequenceA-chain:GIVEQCCTSICS Full viewLength53Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandLantus SoloStarCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1372ThPPIDTh1055NameFollitropin betaPeptide SequenceA Chain: APDVQDCPECT Full viewLength204Functional ClassificationIbDiseaseHormonal disordersBrandFollistim AQCompanyMerckPhysical AppearanceSterile aqueous solution Route of AdministartionSubcutaneous or Intramuscular administrationCategoryFertility Agents TargetFollicle-stimulating hormone receptor
ID1375ThPPIDTh1056NameVasopressinPeptide SequenceCYFQNCPRG
Full view
Length9Functional ClassificationIbDiseaseHormonalBrandPitressinCompanyJHP PharmaceuticalsPhysical AppearanceSterile, aqueous solution of synthetic vasopressinRoute of AdministartionIntramuscular or Subcutaneous useCategoryAntidiuretic Agents TargetVasopressin V2 receptor,Vasopressin V1a receptor,Vasopressin V1b receptor
ID1382ThPPIDTh1060NameInsulin, porcinePeptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIaDiseaseHormonal/MetabolicBrandvetsulinCompanyIntervet Inc (Merck Animal Health)Physical AppearanceSterile injectable suspension in multidose vials containing 10 mL of 40 IU/mL porcine insulin zinc suspensionRoute of AdministartionSubcutaneous InjectionCategoryHypoglycemic Agents TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Hyaluronan, Transforming growth factor beta-1
ID1415ThPPIDTh1069NamePegvisomantPeptide SequenceFPTIPLSRLFDNAMLRAHRL Full viewLength191Functional ClassificationIIaDiseaseHormonalBrandSOMAVERTCompanyPfizerPhysical AppearanceSterile, white lyophilized powder Route of AdministartionSubcutaneous InjectionCategoryHormone Replacement Agents TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1439ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandBRAVELLECompanyFerring Pharmaceuticals Inc.Physical AppearanceSterile, lyophilized powder used after reconstitution with sterile 0.9% Sodium Chloride InjectionRoute of AdministartionIntramuscular and Subcutaneous administration CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1440ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandMetrodinCompanyN.A.Physical AppearanceSterile, lypholized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activityRoute of AdministartionIntramuscular injection.CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1441ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandFertinexCompanyN.A.Physical AppearanceSterile, lyophilized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activityRoute of AdministartionSubcutaneous injection.CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1447ThPPIDTh1080NameChoriogonadotropin AlfaPeptide SequenceAlpha chain: APDVQDC Full viewLength237Functional ClassificationIbDiseaseHormonalBrandChoriogonadotropin alfaCompanyEmd serono inc, Ferring pharmaceuticals inc, App pharmaceuticals llc, Bel mar laboratories inc, BrisPhysical AppearanceN.A.Route of AdministartionN.A.CategoryFertility Agents and Gonadotropins TargetIntegrin alpha-L, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1460ThPPIDTh1087NameOxytocinPeptide SequenceCYIQNCPLG
Full view
Length9Functional ClassificationIbDiseaseHormonalBrandPitocinCompanyJHP PharmaceuticalsPhysical AppearanceSterile, clear, colorless aqueous solution of synthetic oxytocinRoute of AdministartionIntravenous infusionCategoryOxytocics, Anti-tocolytic Agents and Labor Induction Agents TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Globotriaosylceramide
ID1478ThPPIDTh1098NameExenatidePeptide SequenceHGEGTFTSDLSKQMEEEAVR Full viewLength39Functional ClassificationIbDiseaseHormonal/MetabolicBrandBYETTACompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryHypoglycemic Agents TargetGlucagon-like peptide 1 receptor
ID1479ThPPIDTh1098NameExenatidePeptide SequenceHGEGTFTSDLSKQMEEEAVR Full viewLength39Functional ClassificationIbDiseaseHormonal/MetabolicBrandBYDUREONCompanyAmylin PharmaceuticalsPhysical AppearanceWhite to off-white powder that is available in a dosage strength of 2 mg exenatide per vial or per penRoute of AdministartionN.A.CategoryHypoglycemic Agents TargetGlucagon-like peptide 1 receptor
ID1480ThPPIDTh1099NameMecaserminPeptide SequenceGPETLCGAELVDALQFVCGD Full viewLength70Functional ClassificationIbDiseaseHormonalBrandN.A.CompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryN.A. TargetInsulin-like growth factor 1 receptor,Insulin-like growth factor-binding protein 3,Insulin receptor,Cation-independent mannose-6-phosphate receptor
ID1482ThPPIDTh1100NamePramlintidePeptide SequenceKCNTATCATQRLANFLVHSS Full viewLength37Functional ClassificationIaDiseaseHormonal/MetabolicBrandSymlinCompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)Physical AppearanceClear, isotonic, sterile solutionRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
ID1500ThPPIDTh1103NameCosyntropinPeptide SequenceACTH(1-24):
SYSM Full view
Length24Functional ClassificationIVDiseaseHormonalBrandCortrosynCompanyAmphastar PharmaceuticalsPhysical AppearanceN.A.Route of AdministartionIntravenous injection, Intravenous infusion, Intramuscular injectionCategoryHormones and Diagnostic Agents TargetAdrenocorticotropic hormone receptor
ID1501ThPPIDTh1104NameCorticotropinPeptide SequenceSYSMEHFRWGKPVGKKRRPV Full viewLength39Functional ClassificationIVDiseaseHormonalBrandH.P. ActharCompanyQuestcor Pharmaceuticals, Inc.Physical AppearanceN.A.Route of AdministartionN.A.CategoryN.A. TargetN.A.
ID1502ThPPIDTh1105NameInsulin AspartPeptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIaDiseaseHormonal/MetabolicBrandNovoLogCompanyNovo NordiskPhysical AppearanceSterile, aqueous, clear, and colorless solutionRoute of AdministartionSubcutaneous injection, Intravenous injectionCategoryHypoglycemic Agents and Antidiabetic Agents TargetInsulin receptor
ID1503ThPPIDTh1105NameInsulin AspartPeptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIaDiseaseHormonal/MetabolicBrandNovoLog Mix 50/50CompanyNovo NordiskPhysical AppearanceUniform, white, sterile suspension that contains insulin aspartRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents and Antidiabetic Agents TargetInsulin receptor
ID1504ThPPIDTh1105NameInsulin AspartPeptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIaDiseaseHormonal/MetabolicBrandNovoLog Mix 70/30CompanyNovo NordiskPhysical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL.Route of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents and Antidiabetic Agents TargetInsulin receptor
ID1511ThPPIDTh1106NameInsulin DetemirPeptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIaDiseaseHormonal/MetabolicBrandLEVEMIRCompanyNovo NordiskPhysical AppearanceClear, colorless, aqueous, neutral sterile solutionRoute of AdministartionSubcutaneous injectionCategoryAntidiabetic Agents TargetInsulin receptor
ID1520ThPPIDTh1107NameInsulin GlulisinePeptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIbDiseaseHormonal/MetabolicBrandAPIDRACompanysanofi-aventisPhysical AppearanceSterile, aqueous, clear, and colorless solutionRoute of AdministartionN.A.CategoryAntidiabetic Agents TargetInsulin receptor
ID1549ThPPIDTh1118NameSulodexidePeptide SequenceN.A. Full viewLength0Functional ClassificationIIIcDiseaseHormonal/genetic/Hematological/N.A.BrandSULODEXIDECompanySyntex S.APhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntithrombins and Fibrinolytic Agents and Hypoglycemic Agents and Anticoagulants and Hypolipidemic Agents TargetHeparin cofactor 2,Antithrombin-III
ID1576ThPPIDTh1124NameLiraglutidePeptide SequenceHAEGTFTSDVSSYLEGQAAK Full viewLength33Functional ClassificationIbDiseaseHormonalBrandSaxendaCompanyNovo NordiskPhysical AppearanceClear, colorless solutionRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetGlucagon-like peptide 1 receptor
ID1577ThPPIDTh1124NameLiraglutidePeptide SequenceHAEGTFTSDVSSYLEGQAAK Full viewLength33Functional ClassificationIbDiseaseHormonalBrandVictozaCompanyNovo NordiskPhysical AppearanceClear, colorless solution.Route of AdministartionSubcutaneous injectionCategoryN.A. TargetGlucagon-like peptide 1 receptor
ID1600ThPPIDTh1127NameBuserelinPeptide SequenceN.A. Full viewLength0Functional ClassificationIIIcDiseaseCancer/HormonalBrandSuprecur (Nasal Spray Solution)CompanySanofi-AventisPhysical Appearance150 micrograms Nasal Spray SolutionRoute of AdministartionNasal sprayCategoryN.A. TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1601ThPPIDTh1127NameBuserelinPeptide SequencepGlu-His-Trp-Ser-Tyr Full viewLength9Functional ClassificationIIIcDiseaseCancer/HormonalBrandSuprecur (injection)CompanySanofi-AventisPhysical Appearance1mg/ml InjectionRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1602ThPPIDTh1128NameVelaglucerase AlfaPeptide SequenceARPCIPKSFGYSSVVCVCNA Full viewLength497Functional ClassificationIaDiseaseHormonalBrandVPRIVCompanyShirePhysical AppearanceSterile, preservative free, lyophilized powderRoute of AdministartionIntravenous infusionCategoryEnzymes TargetGlucosylceramidase
ID1603ThPPIDTh1129NameTesamorelinPeptide SequenceYADAIFTNSYRKVLGQLSAR Full viewLength44Functional ClassificationIbDiseaseHormonalBrandEgriftaCompanyTheratechnologiesPhysical AppearanceSterile, white to off-white, preservative-free lyophilized powderRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetGrowth hormone-releasing hormone receptor
ID1608ThPPIDTh1131NameTaliglucerase AlfaPeptide SequenceEFARPCIPKSFGYSSVVCVC Full viewLength504Functional ClassificationIaDiseaseHormonalBrandElelysoCompanyPfizerPhysical AppearanceSterile, non-pyrogenic, lyophilized product.Route of AdministartionIntravenous infusionCategoryEnzymes TargetGlucocerebroside
ID1621ThPPIDTh1134NameAsparaginase Erwinia ChrysanthemiPeptide SequenceADKLPNIVILATGGTIAGSA Full viewLength327Functional ClassificationIcDiseaseHormonalBrandErwinazeCompanyEUSA PharmaPhysical AppearanceSterile, lyophilized, white powder in vials.Route of AdministartionIntramuscular injectionCategoryEnzymes TargetN.A.
ID1623ThPPIDTh1136NameGlucarpidasePeptide SequenceALAQKRDNVLFQAATDEQPA Full viewLength393Functional ClassificationIcDiseaseHormonalBrandVoraxazeCompanyBTG InternationalPhysical AppearanceSterile, preservative-free, white lyophilized powder in single-use vialsRoute of AdministartionIntravenous injectionCategoryEnzymes TargetMethotrexate
ID1634ThPPIDTh1140NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn)Peptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIaDiseaseHormonal/MetabolicBrandNovolin NCompanyNovo NordiskPhysical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe)Route of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents and Antidiabetic Agents TargetInsulin receptor
ID1638ThPPIDTh1144NameFollitropin AlphaPeptide SequenceN.A. Full viewLength0Functional ClassificationIbDiseaseAdjunct therapy/ HormonalBrandGonal-FCompanySerono LaboratoriesPhysical AppearanceSterile, lyophilized powder.Route of AdministartionSubcutaneous injectionCategoryN.A. TargetN.A.
ID1639ThPPIDTh1144NameFollitropin AlphaPeptide SequenceN.A. Full viewLength0Functional ClassificationIbDiseaseAdjunct therapy/ HormonalBrandGonal-f RFFCompanyEMD SERONOPhysical AppearanceSterile, lyophilized powdeRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetN.A.
ID1655ThPPIDTh1151NameSomatotropin RecombinantPeptide SequenceFPTIPLSRLFDNAMLRAHRL Full viewLength192Functional ClassificationIbDiseaseHormonal/MetabolicBrandNutropinAQCompanyGenentech Inc.Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic WaterRoute of AdministartionSubcutaneous administrationCategoryHormone Replacement Agents TargetGrowth hormone receptor, Prolactin receptor
ID1656ThPPIDTh1151NameSomatotropin RecombinantPeptide SequenceFPTIPLSRLFDNAMLRAHRL Full viewLength192Functional ClassificationIbDiseaseHormonal/MetabolicBrandBioTropinCompanyBio-Technology General (Israel) Ltd.Physical AppearanceSterile, white, lyophilized powderRoute of AdministartionSubcutaneous administrationCategoryHormone Replacement Agents TargetGrowth hormone receptor, Prolactin receptor